Ring Mountain Capital’s Eli Lilly LLY Stock Holding History

Ring Mountain Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$404K	Buy	349 +19	+6%	+$22.4K	0.16%	69
2026 Q2	$396K	Buy	330 +3	+0.9%	+$3.06K	0.17%	66
2026 Q1	$301K	Sell	327 -6	-2%	-$6.08K	0.16%	71
2025 Q4	$346K	Sell	333 -3	-0.9%	-$2.87K	0.18%	71
2025 Q3	$256K	Buy	336 +5	+2%	+$3.72K	0.14%	84
2025 Q2	$255K	Sell	331 -342	-51%	-$266K	0.16%	82
2025 Q1	$556K	Sell	673 -18	-3%	-$15K	0.42%	42
2024 Q4	$533K	Buy	+691	New	+$572K	0.36%	45

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Ring Mountain Capital's LLY Position: Q3 2026 in Review

Ring Mountain Capital increased its Eli Lilly (LLY) stake by 5.8% in Q3 2026, buying an estimated $22.4K and bringing the position to 349 shares worth $404K. The position accounts for 0.16% of the portfolio, ranked #69.

Ring Mountain Capital first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $556K in Q1 2025. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Ring Mountain Capital held 349 shares of Eli Lilly worth $404K as of Q3 2026.
Ring Mountain Capital bought 19 Eli Lilly shares in Q3 2026, an estimated $22.4K.
Eli Lilly made up 0.16% of Ring Mountain Capital's portfolio in Q3 2026, its #69 holding.
Ring Mountain Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
Ring Mountain Capital's Eli Lilly position peaked at $556K in Q1 2025.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ring Mountain Capital's 13F filing for Q3 2026, filed 13 Oct 2026.